Stephen OHara - Ingen Technologies Director

Director

Dr. Stephen OHara, M.D., is a Director of Ingen Technologies, Inc. The Consumer Research Council of America, an independent organization based in Washington, D.C. recently ranked Dr. Stephen OHara among the top two percent of clinical neurologists nationwide. He attended Stanford University and graduated in 1975 with a BS degree in biology and performed honors research in the laboratory of Dr. Donald Kennedy, who subsequently served as President of Stanford University. Dr. OHara obtained his M.D. from Northwestern University in 1979, where he became president of the Northwestern chapter of the American Medical Student Association, then proceeded to complete his residency in neurology at UCLA in 1983 since 2005.
Age 56
Tenure 19 years
Professional MarksPh.D
Phone951-688-7840
Webhttps://www.ingen-tech.com
O'Hara is boardcertified in neurology through the American Board of Psychiatry and Neurology. Since completing his residency, Dr. O'Hara has continued to teach the residents in the neurology program at UCLA while maintaining a private practice in Century City, California for the past 16 years with an emphasis on geriatric neurology and disorders of balance.

Similar Executives

Showing other executives

DIRECTOR Age

Jeffrey RhodesZimmer Biomet Holdings
41
Jay SkylerDexCom Inc
71
Nicholas ValerianiEdwards Lifesciences Corp
64
Louise FrancesconiStryker
66
Gregory SantoraAlign Technology
66
David RouxBoston Scientific Corp
67
Samuel ScottAbbott Laboratories
75
John CardisEdwards Lifesciences Corp
73
David NagelAlign Technology
68
Darren McDewAbbott Laboratories
60
Roch DoliveuxStryker
64
Edward LiddyAbbott Laboratories
74
Donna JamesBoston Scientific Corp
63
Stephen MacMillanBoston Scientific Corp
56
Gail BoudreauxZimmer Biomet Holdings
59
Daniel StarksAbbott Laboratories
66
Charles DockendorffBoston Scientific Corp
66
Robert HagemannZimmer Biomet Holdings
64
Michael MichelsonZimmer Biomet Holdings
69
Christopher BegleyZimmer Biomet Holdings
68
Steven LorangerEdwards Lifesciences Corp
69
Ingen Technologies, Inc., a medical device manufacturing company, manufactures medical products for the respiratory industry in United States. Ingen Technologies, Inc. was founded in 1999 and is based in Riverside, California. INGEN TECHNOLOGIES operates under Medical Devices classification in the United States and is traded on PNK Exchange. Ingen Technologies [IGNT] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Ingen Technologies Leadership Team

Elected by the shareholders, the Ingen Technologies' board of directors comprises two types of representatives: Ingen Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingen. The board's role is to monitor Ingen Technologies' management team and ensure that shareholders' interests are well served. Ingen Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingen Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Wirth, Director
Stephen OHara, Director
John Finazzo, Director
Richard Weed, G Counsel
Yong Khoo, Director
Thomas Neavitt, Interim CEO, CFO, Principal Accounting Officer, Controller and Director
Richard Campbell, Director
David Hanson, CEO Director
Charles Vorwaller, Executive VP of National Product Distribution
David Holland, Director
Gary Tilden, Chairman, Chief Operations Officer and Secretary
Curt Miedema, Director
Donn Miller, Director
Michael Cooper, Director

Ingen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ingen Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ingen Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ingen Technologies' short interest history, or implied volatility extrapolated from Ingen Technologies options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ingen Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Ingen Pink Sheet analysis

When running Ingen Technologies' price analysis, check to measure Ingen Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingen Technologies is operating at the current time. Most of Ingen Technologies' value examination focuses on studying past and present price action to predict the probability of Ingen Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingen Technologies' price. Additionally, you may evaluate how the addition of Ingen Technologies to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance
Please note, there is a significant difference between Ingen Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ingen Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ingen Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.